MyFinsight
Home
Blog
About
Back
Income Statement
Elicio Therapeutics, Inc. (ELTX)
Elicio Therapeutics, Inc. (ELTX)
source: myfinsight.com
Comprehensive loss
-$8,221K
(21.61%↑ Y/Y)
Change in fair value of
warrant liabilities
-$2,483K
(-389.06%↓ Y/Y)
Interest income
$138K
(-17.86%↓ Y/Y)
Foreign exchange
transaction gain
$1K
Net loss
-$8,217K
(22.19%↑ Y/Y)
Foreign currency
translation adjustment
-$4K
(-105.41%↓ Y/Y)
Total other income
(expense), net
$2,212K
(570.64%↑ Y/Y)
Interest expense
$410K
(111.34%↑ Y/Y)
Loss from operations
-$10,429K
(-3.35%↓ Y/Y)
Total operating
expenses
$10,429K
(3.35%↑ Y/Y)
Research and development
$6,811K
(-2.78%↓ Y/Y)
General and
administrative
$3,618K
(17.28%↑ Y/Y)
Back